The Addition of Fenofibrate to Ursodiol Improves Levels of Alkaline Phosphatase Among Patients with Primary Biliary Cholangitis That Do Not Respond to Ursodeoxycholic Acid Monotherapy

被引：0
|
作者：
Adekunle, Oreoluwa [1 ]
Gupta, Udita [1 ]
Chapman, Malcolm [1 ]
Richman, Joshua [1 ]
Gray, Meagan [1 ]
Ravi, Sujan [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1451
引用
收藏
页码：S1108 / S1108
页数：1
相关论文
共 50 条
  • [31] Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis
    Tanaka, Atsushi
    Hirohara, Junko
    Nakano, Toshiaki
    Yagi, Minami
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    Nakanuma, Yasuni
    Takikawa, Hajime
    HEPATOLOGY RESEARCH, 2018, 48 (09) : 727 - 734
  • [32] Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis
    Matsumoto, Kosuke
    Hirohara, Junko
    Takeuchi, Akihito
    Miura, Ryo
    Asaoka, Yoshinari
    Nakano, Toshiaki
    Tanaka, Atsushi
    HEPATOLOGY RESEARCH, 2023, 53 (10) : 989 - 997
  • [33] The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort
    Werner, Ellen
    van Hooff, Maria C.
    van der Maas, Gerjan J.
    de Veer, Rozanne C.
    Beuers, Ulrich
    Drenth, Joost P. H.
    Cuperus, Frans J. C.
    van Hoek, Bart
    Veldt, Bart J.
    Klemt-Kropp, Michael
    van Meer, Suzanne
    Verdonk, Robert C.
    Flink, Hajo J.
    Vrolijk, Jan Maarten
    Gevers, Tom J. G.
    Ponsioen, Cyriel Y.
    de Kort, Sander
    van Putten, Paul G.
    Cahen, Djuna L.
    van der Waaij, Lauren A.
    Thio, Hans H. K.
    Schreuder, Tim C. M. A.
    van Dam, Lisette J. H.
    Epping, Ludger S. M.
    Jurgens, Matthias C.
    Cazemier, Marcel
    van Kemenade, J.
    Kuiper, Edith M. M.
    Beukema, Menno
    ter Borg, Martijn J.
    Soufidi, Khalida
    Janssen, Harry L. A.
    Hansen, Bettina E.
    Erler, Nicole S.
    van der Meer, Adriaan J.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S319 - S320
  • [34] EVALUATION OF PROGNOSTIC MODELS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS RECEIVING URSODEOXYCHOLIC ACID
    Alomari, Mohammad
    Covut, Fahrettin
    Chadalavada, Pravallika
    Gunasekaran, Deepthi
    Padbidri, Vinay S.
    Al Momani, Laith
    Khazaaleh, Shrouq
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2019, 156 (06) : S1321 - S1321
  • [35] A Retrospective Analysis of Ten Patients with Normal Alkaline Phosphatase and Primary Biliary Cholangitis
    Mony, Shruti
    Vyas, Neil
    Quigley, Gerard
    Chuang, Keng-Yu
    Nadir, Abdul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1520 - S1521
  • [36] Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
    Levy, C.
    Peter, J. A.
    Nelson, D. R.
    Keach, J.
    Petz, J.
    Cabrera, R.
    Clark, V.
    Firpi, R. J.
    Morelli, G.
    Soldevila-Pico, C.
    Lindor, K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 235 - 242
  • [37] Additive effect of fenofibrate on primary biliary cirrhosis patients undergoing ursodeoxycholic acid treatment
    Sasaki, Masato
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 230 - 230
  • [38] Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis
    Ellez, H. I.
    Danis, N.
    Akarca, U. S.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2024, 87 (02) : 282 - 286
  • [39] External Validation of the United Kingdom-Primary Biliary Cholangitis Risk Scores of Patients With Primary Biliary Cholangitis Treated With Ursodeoxycholic Acid
    Cheung, Angela C.
    Gulamhusein, Aliya F.
    Juran, Brian D.
    Schlicht, Erik M.
    Mccauley, Bryan M.
    De Andrade, Mariza
    Atkinson, Elizabeth J.
    Lazaridis, Konstantinos N.
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (06) : 676 - 682
  • [40] Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators
    Qian, Jian-Dan
    Yao, Tian-Tian
    Wang, Yan
    Wang, Gui-Qiang
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (06) : 874 - 884
12345